My hematologist spoke about this drug at my last visit. He was extremely positive and excited that the side effects were so few compared to the predecessors in this drug class. Smaller dose -- better impact -- less side effects.

This is fantastic news. I hope it works as well as they say. It gives new hope to so many of us.

JamieW, thank you for this information! I have been in the COMMANDER study at University of Alabama-Birmingham investigating the use of iberdomide since February 2025. I have been doing very well, very good labs, and very few side effects. A BMB is scheduled for this summer to assess MRD. My doctor told me that many of the other study participants who have been involved for going on 3 years continue to show very good responses. I am excited to hear that this treatment is on track to be more widely offered. I am also grateful that there are many new treatments being developed and remain optimistic that there will be a discovery that will prevent these abnormal cells from being produced in the first place!!!

Hey JamieW, the first 6 months my treatment was DarzalexFaspro and dexamethasone weekly, then biweekly while taking iberdomide 21 days on, 7 days off. Beginning in August 2025, my treatment was only iberdomide 21 days on, 7 days off, with labs monthly.

Thanks for the info JamieW, looks like a promising drug with more potency to fight MM and less side effect. Hope it doesn't cost an arm and a leg.